Cohen, Debbie L. http://orcid.org/0000-0002-1325-315X
Weinberg, Ido
Uretsky, Seth
Popma, Jeffrey J.
Almonacid, Alexandra
Hadley, Gail
Cohen, Sidney A.
Townsend, Raymond R.
Article History
Received: 22 November 2020
Accepted: 8 February 2021
First Online: 1 March 2021
Compliance with ethical standards
:
: Dr. DL Cohen: site PI for Symplicity HTN3, SPYRAL on MED and Spyral off med studies, Radiance study, Dr. Weinberg: consulting for Magneto Thrombectomy Solutions, Dr. Uretsky: none, Dr. Popma: employee and shareholder of Medtronic, Dr. Almonacid: Institutional Grants: Boston Scientific, Medtronic, Abbott Vascular, COOK, Terumo. Dr. Alexandra Almonacid-Popma receives no personal fees. Her spouse joined Medtronic as an employee after completion of the angiographic methodology for the RDN Spyral ON and OFF studies but prior to this publication. Ms. Hadley: none, Dr. SA Cohen: employee and shareholder of Medtronic. Dr. Townsend: medtronic Consultant; UpToDate Contributor, NIH Grants, AXIO DSMB Member, Regeneron Consultant; Ionis Consultant.